Presentation delivered by Dr Nadia Teleb, Regional Adviser, Vaccine Preventable Diseases at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Global vaccine action plan
1. The Global Vaccine Action Plan
Agenda item 5(c)
62nd Session of the WHO Regional Committee for the Eastern
Mediterranean
58 October 2015
1
2. Outline
• Global Vaccine Action Plan
– Goals
– Regional progress
– Challenges faced in the Region
• Draft Eastern Mediterranean Vaccine Action
Plan 20162020
– Vision
– Goals
– Strategic objectives
– Monitoring and evaluation framework
– What is expected from the Member States
2
The Global Vaccine Action Plan
3. The Global Vaccine Action Plan
• Operational framework
for implementation of the
vision and mission of and
achieving the goals of the
Decade of Vaccines
20112020
• Endorsed by the World
Health Assembly in May
2012 (resolution
WHA65.17)
3
The Global Vaccine Action Plan
4. Goals of the Decade of Vaccines
• Achieve a world free of polio
• Meet vaccination coverage targets in
every region, country and community
• Meet global and regional elimination
targets
• Develop and introduce new and improved
vaccines and technologies
• Exceed the MDG 4 target for reduction of
child mortality
4
The Global Vaccine Action Plan
7. WHOUNICEF estimates of DTP3
coverage, 2014
0
10
20
30
40
50
60
70
80
90
100
%coverage
Source: WHOUNICEF estimates 7
The Global Vaccine Action Plan
8. DTP3
unvaccinated
3.2 million,
19%
DTP3
vaccinated
14.2 million,
81%
DTP3 unvaccinated
DTP3 vaccinated
DTP3: 3.2 million unvaccinated
infants in the Region, 2014
Source: WHOUNICEF estimates
Pakistan
47%
Iraq
14%
Afghanistan
10%
Syrian Arab
Republic
10%
Somalia
6%
Egypt
4%
Yemen
3%
Sudan
3%
others
3%
8
The Global Vaccine Action Plan
9. Source: Countries’ reports
Kuwait: no reports in 2014
EMR incidence rate: 14.79/million
113.7
54.0
41.6
35.5 34.9
30.3
28.1 26.5
20.8 20.7 20.4
7.7 6.9
4.4
2.4 1.6 0.9 0.8 0.3 0.0 0.0
0
20
40
60
80
100
120
Incidence/millionpopulation
Incidence rate of confirmed
measles cases, 2014
<1/millionpopulation
High endemicity/major outbreaks
15/millionpopulation
Source: National reports
9
The Global Vaccine Action Plan
10. Palestine
Maternal and neonatal tetanus
elimination
Bahrain
MNT not eliminated
MNT eliminated
10
The Global Vaccine Action Plan
11. New vaccine introduction
Currently
offered to
65% of live
births
Palestine
Bahrain
Pneumococcal
vaccine introduction
Introduced (14)
Not introduced (8)
Palestine
Bahrain
Rotavirus
vaccine introduction
Introduced (11)
Not introduced (11)
Currently
offered to
30% of live
births
11
12. Challenges and constraints
• The geopolitical situation in several countries
• Inadequate managerial capacity coupled with the
multiple competing priorities in some countries
• Inadequate attention to or visibility of the immunization
goals other than polio eradication
• Inadequate allocation of domestic resources
• Inadequate vaccine registration and procurement
systems
• Inadequate social mobilization and demand creation
• Weak surveillance systems for vaccine-preventable
diseases and poor immunization data quality in some
countries
12
The Global Vaccine Action Plan
14. EMVAP 20162020
• Developed in response to resolution
WHA65.17
• A framework for implementation of the Global
Vaccine Action Plan
• Renews commitments of Member States to
the global and regional immunization goals
• Defines the objectives, priority actions and
indicators of immunization programmes,
taking into account specific needs and
challenges of countries of the Region
14
The Global Vaccine Action Plan
15. EMVAP 20162020
• Vision: a region in which all individuals
enjoy lives free of vaccine-preventable
diseases
• Aims at ensuring equitable access, of all
communities and individuals, especially
those marginalized and in hard-to-reach
areas, to sustainable access to vaccines
of assured qualities
15
The Global Vaccine Action Plan
16. Goals
1. Attain interruption and sustain polio-free status
2. Meet regional routine vaccination coverage
targets at all administrative levels
3. Meet regional disease elimination and control
targets
– Achieving measles elimination
– Achieving and sustaining elimination of maternal and
neonatal tetanus
– Achieving the regional hepatitis B reduction goal
4. Introduce new vaccines of regional and national
priority
16
The Global Vaccine Action Plan
17. Strategic objectives
1. All countries commit to immunization as a priority
2. Individuals and communities understand the value of
vaccines and demand vaccination as their rights and
responsibilities
3. The benefits of vaccination are extended
equitably to all people through tailored, innovative
strategies
4. Strong immunization systems are an integral part of a
well-functioning health system
5. Immunization programmes have sustainable access
to long term funding and high-quality supply
17
The Global Vaccine Action Plan
18. Priority actions
• EMVAP proposes a list of priority actions
for each strategic objective
• Priority actions are tailored to address:
– the current situation of immunization
programmes in the Region
– specificities and challenges currently faced by
the Region
18
The Global Vaccine Action Plan
19. Monitoring and evaluation
framework
• EMVAP 20162020 proposes a monitoring
and evaluation framework with specific
indicators for:
– monitoring implementation of the priority
actions of the different strategic objectives
– monitoring progress towards achieving the
goals of the plan
– reporting to the Regional Committee annually
on the progress made and remaining
challenges
19
The Global Vaccine Action Plan
20. What is expected from Member States
• Renewing commitments to immunization
programmes
• Providing input to and endorsing EMVAP
20162020
• Using EMVAP as a framework for developing and
updating the comprehensive multiyear plans
(cMYP) for immunization in order to achieve the
regional immunization goals
• Allocating and mobilizing resources necessary for
implementation of EMVAP 20162020
20
The Global Vaccine Action Plan